IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1238.2540.1 (+3.35 %)
PREV CLOSE ( ) 1198.15
OPEN PRICE ( ) 1200.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 65795
TODAY'S LOW / HIGH ( )1200.65 1245.00
52 WK LOW / HIGH ( )670 1264
NSE1237.4032.1 (+2.66 %)
PREV CLOSE( ) 1205.30
OPEN PRICE ( ) 1205.40
BID PRICE (QTY) 1237.40 (675)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 668011
TODAY'S LOW / HIGH( ) 1202.35 1245.00
52 WK LOW / HIGH ( )669.8 1263.95
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax7452.9011357.2013889.807388.905464.60
Adjustment2351.801951.101830.702473.701873.60
Changes In working Capital489.90-2727.20-2363.30-2636.90-1219.70
Cash Flow after changes in Working Capital10294.6010581.1013357.207225.706118.50
Cash Flow from Operating Activities8058.108560.7010901.305703.505010.30
Cash Flow from Investing Activities-7250.00-8550.50-5206.90-5096.50-1650.60
Cash Flow from Financing Activities5072.404267.80-3058.20-1365.40-1832.00
Net Cash Inflow / Outflow5880.504278.002636.20-758.401527.70
Opening Cash & Cash Equivalents9909.305590.102953.903709.202181.50
Cash & Cash Equivalent on Amalgamation / Take over / MergerNA41.20NA3.10NA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent15789.809909.305590.102953.903709.20

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.